Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1999:34 Suppl:S1-3.
doi: 10.1007/BF02562220.

Essentiality of fatty acids

Affiliations
Review

Essentiality of fatty acids

A A Spector. Lipids. 1999.

Abstract

All fatty acids have important functions, but the term "essential" is applied only to those polyunsaturated fatty acids (PUFA) that are necessary for good health and cannot be completely synthesized in the body. The need for arachidonic acid, which is utilized for eicosanoid synthesis and is a constituent of membrane phospholipids involved in signal transduction, is the main reason why the n-6 class of PUFA are essential. Physiological data indicate that n-3 PUFA also are essential. Although eicosapentaenoic acid also is a substrate for eicosanoid synthesis, docosahexaenoic acid (DHA) is more likely to be the essential n-3 constituent because it is necessary for optimal visual acuity and neural development. DHA is present in large amounts in the ethanolamine and serine phospholipids, suggesting that its function involves membrane structure. Because the metabolism of n-6 PUFA is geared primarily to produce arachidonic acid, only small amounts of 22-carbon n-6 PUFA are ordinarily formed. Thus, the essentiality of n-3 PUFA may be due to their ability to supply enough 22-carbon PUFA for optimal membrane function rather than to a unique biochemical property of DHA.

PubMed Disclaimer

References

    1. Biochim Biophys Acta. 1984 Sep 12;795(2):277-85 - PubMed
    1. J Lipid Res. 1998 May;39(5):978-86 - PubMed
    1. Biochem J. 1986 May 15;236(1):235-42 - PubMed
    1. Mol Pharmacol. 1995 Feb;47(2):381-90 - PubMed
    1. J Neurochem. 1982 Mar;38(3):650-6 - PubMed

Publication types

LinkOut - more resources